QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 4,900.00
+30.00 (0.62%)
At close: Sep 3, 2026
QuadMedicine Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 8,158 | 26,507 | 10,263 | 4,449 |
Short-Term Investments | 9,510 | 1,010 | - | - |
Cash & Short-Term Investments | 17,668 | 27,517 | 10,263 | 4,449 |
Cash Growth | 225.66% | 168.12% | 130.69% | - |
Accounts Receivable | 4,950 | 1,803 | 1,100 | 18.41 |
Other Receivables | 84.46 | 393.82 | 3.22 | 0.23 |
Receivables | 5,756 | 2,974 | 1,103 | 18.64 |
Prepaid Expenses | 2.13 | 8.05 | 86.89 | 512.18 |
Other Current Assets | 573.97 | 540.93 | 232.97 | 69.03 |
Total Current Assets | 24,008 | 31,040 | 11,686 | 5,049 |
Property, Plant & Equipment | 20,890 | 19,299 | 19,752 | 19,549 |
Long-Term Investments | 3,003 | - | 10 | - |
Other Intangible Assets | 575.45 | 597.95 | 493.21 | 364.21 |
Long-Term Accounts Receivable | -0 | -0 | -0 | -0 |
Other Long-Term Assets | 272.68 | 242.17 | 157.35 | 257.19 |
Total Assets | 48,748 | 51,179 | 32,098 | 25,219 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt | 2,000 | 500 | 500 | - |
Current Portion of Long-Term Debt | 5,800 | 5,900 | 99.6 | - |
Current Portion of Leases | 321.37 | 283.22 | 206.35 | 295.71 |
Other Current Liabilities | 7,048 | 4,138 | 5,524 | 3,616 |
Total Current Liabilities | 15,169 | 10,821 | 6,330 | 3,912 |
Long-Term Debt | - | 551 | 6,451 | 5,800 |
Long-Term Leases | 287.69 | 249.76 | 106.84 | 327.7 |
Other Long-Term Liabilities | 8,745 | 8,759 | 7,611 | 6,217 |
Total Liabilities | 24,202 | 20,380 | 20,498 | 16,256 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 5,741 | 5,671 | 4,676 | 4,358 |
Additional Paid-In Capital | 72,840 | 71,338 | 45,483 | 38,472 |
Retained Earnings | -55,575 | -48,619 | -41,688 | -36,720 |
Comprehensive Income & Other | 1,541 | 2,409 | 3,128 | 2,853 |
Shareholders' Equity | 24,547 | 30,799 | 11,600 | 8,963 |
Total Liabilities & Equity | 48,748 | 51,179 | 32,098 | 25,219 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 8,409 | 7,484 | 7,363 | 6,423 |
Net Cash (Debt) | 9,259 | 20,033 | 2,899 | -1,975 |
Net Cash Growth | - | 590.96% | - | - |
Net Cash Per Share | 868.95 | 2086.14 | 332.59 | -228.65 |
Filing Date Shares Outstanding | 11.46 | 11.34 | 9.35 | 8.74 |
Total Common Shares Outstanding | 11.46 | 11.34 | 9.35 | 8.74 |
Working Capital | 8,838 | 20,219 | 5,356 | 1,137 |
Book Value Per Share | 2142.49 | 2715.63 | 1240.40 | 1025.97 |
Tangible Book Value | 23,971 | 30,201 | 11,107 | 8,599 |
Tangible Book Value Per Share | 2092.26 | 2662.91 | 1187.66 | 984.28 |
Land | 2,409 | 2,187 | 2,187 | 1,951 |
Buildings | 10,681 | 9,683 | 9,683 | 8,572 |
Machinery | 11,628 | 10,997 | 9,130 | 7,681 |
Construction In Progress | 1,174 | 317.24 | 171.69 | 555.41 |